QNRX
Quoin Pharmaceuticals Ltd DRC
NASDAQ: QNRX · HEALTHCARE · BIOTECHNOLOGY
$6.21
-4.17% today
Updated 2026-05-01
Market cap
$9.83M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-14.80
Dividend yield
—
52W range
$5 – $24
Volume
0.1M
Quoin Pharmaceuticals Ltd DRC (QNRX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-141.60%
ROA
-56.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | — | $-2.62M | — | — | — |
| 2016 | $-280000.00 | $15.32M | 100.00% | -5,470.36% | -5,470.36% |
| 2017 | — | $10.17M | — | — | — |
| 2018 | $-280000.00 | $15.32M | 100.00% | -5,470.36% | -5,470.36% |
| 2019 | $0.00 | $-1.56M | — | — | — |
| 2020 | $0.00 | $-2.10M | — | — | — |
| 2021 | $0.00 | $-21.46M | — | — | — |
| 2022 | $0.00 | $-9.38M | — | — | — |
| 2023 | $0.00 | $-8.69M | — | — | — |
| 2024 | $0.00 | $-8.96M | — | — | — |
| 2025 | $0.00 | $-15.80B | — | — | — |